Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy
Author:
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1586/1744666X.2014.875856
Reference98 articles.
1. Interleukin-2: Inception, Impact, and Implications
2. Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
3. Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
4. Structural Biology of Shared Cytokine Receptors
5. Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends;Experimental & Molecular Medicine;2024-09-02
2. Association of CTACK, IL-2, and IL-13 with increased risk of lung cancer: A Mendelian randomization study;Cytokine;2024-09
3. Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals;Journal of Drug Targeting;2024-08-07
4. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22
5. Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity;Signal Transduction and Targeted Therapy;2024-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3